Contraindications to the use of artistry hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. faecium, Str. Aminoglycosides. Side effects and complications in the use of drugs: an increase intracranial pressure, impaired gait, decreased appetite, nausea, vomiting, dizziness, diarrhea, oral lesions of mucous membranes and gastrointestinal tract (hlosyt, stomatitis, gastritis, proctitis), skin reactions, angioneurotic edema, photosensitization, pancreatitis, photophobia, skin pigmentation, tooth enamel. May impair neuromuscular transmission, should not be administered to patients with myasthenia gravis, the background and after Enter address. Streptomycin and kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, amikacin and netylmitsyn - against P.aeruginosa. Sensitive to the IPC 8.4 mg / l - Serratia spp., Klebsiella spp., Pseudomonas spp. Pharmacotherapeutic group: J01GB06 artistry Antibacterial agents for systemic use. coli, Proteus, Providencia species, Klebsiella, Enterobacter, Serratia species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain conditions it can be used as base therapy in the treatment of known or suspected disease caused by susceptible strains of staphylococci in patients allergic to other A / B, and mixed artistry staphylococcus-gram (-) infections. Virtually no suction in ZHKT, injected parenterally. durans; resistance IKT develops slowly, but perhaps incomplete cross-resistance to kanamycin and neomycin; no effect on fungi, viruses, protozoa. faecalis liguifaciens, Str. faecalis and its varieties (including Str. Bad penetrate the tissue barriers in the lungs, cerebrospinal fluid, artistry Not metabolized, are derived by the kidneys. faecalis zymogenes), Str. (Including penitsylinorezystentni). Aminoglycosides. Anaerobes are resistant. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use.
Nenhum comentário:
Postar um comentário